Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer.

Shah NM, Scott DM, Kandagatla P, Moravek MB, Cobain EF, Burness ML, Jeruss JS.

Ann Surg Oncol. 2019 May;26(5):1214-1224. doi: 10.1245/s10434-019-07156-7. Epub 2019 Jan 24.

PMID:
30680478
2.

Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure.

Marcath LA, Kidwell KM, Robinson AC, Vangipuram K, Burness ML, Griggs JJ, Poznak CV, Schott AF, Hayes DF, Henry NL, Hertz DL.

Pharmacogenomics. 2019 Jan;20(2):95-104. doi: 10.2217/pgs-2018-0162. Epub 2018 Dec 6.

PMID:
30520341
3.

Tamoxifen and ERα36: Fertilizing the seeds of breast cancer metastasis.

Burness ML, Wicha MS.

Cell Res. 2018 Apr;28(4):391-392. doi: 10.1038/s41422-018-0028-4. No abstract available.

4.

High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells.

Lin E, Rivera-Báez L, Fouladdel S, Yoon HJ, Guthrie S, Wieger J, Deol Y, Keller E, Sahai V, Simeone DM, Burness ML, Azizi E, Wicha MS, Nagrath S.

Cell Syst. 2017 Sep 27;5(3):295-304.e4. doi: 10.1016/j.cels.2017.08.012. Epub 2017 Sep 20.

5.

RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer.

Liu Y, Burness ML, Martin-Trevino R, Guy J, Bai S, Harouaka R, Brooks MD, Shang L, Fox A, Luther TK, Davis A, Baker TL, Colacino J, Clouthier SG, Shao ZM, Wicha MS, Liu S.

Clin Cancer Res. 2017 Jan 15;23(2):514-522. doi: 10.1158/1078-0432.CCR-15-1348. Epub 2016 Dec 29.

6.

Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone.

Price TT, Burness ML, Sivan A, Warner MJ, Cheng R, Lee CH, Olivere L, Comatas K, Magnani J, Kim Lyerly H, Cheng Q, McCall CM, Sipkins DA.

Sci Transl Med. 2016 May 25;8(340):340ra73. doi: 10.1126/scitranslmed.aad4059.

PMID:
27225183
7.

Tunable Thermal-Sensitive Polymer-Graphene Oxide Composite for Efficient Capture and Release of Viable Circulating Tumor Cells.

Yoon HJ, Shanker A, Wang Y, Kozminsky M, Jin Q, Palanisamy N, Burness ML, Azizi E, Simeone DM, Wicha MS, Kim J, Nagrath S.

Adv Mater. 2016 Jun;28(24):4891-7. doi: 10.1002/adma.201600658. Epub 2016 Apr 26.

8.

Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer.

Brooks MD, Burness ML, Wicha MS.

Cell Stem Cell. 2015 Sep 3;17(3):260-71. doi: 10.1016/j.stem.2015.08.014. Review.

9.

Triple negative breast cancer in BRCA1 mutation carriers with a complete radiologic response to neoadjuvant paclitaxel: a case report.

Burness ML, Obeid EI, Olopade OI.

Clin Breast Cancer. 2015 Apr;15(2):e155-8. doi: 10.1016/j.clbc.2014.08.006. Epub 2014 Sep 28. No abstract available.

PMID:
25445425
10.

Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?

Burness ML, Olopade OI.

J Clin Oncol. 2011 May 1;29(13):1652-4. doi: 10.1200/JCO.2010.32.5274. Epub 2011 Mar 28. No abstract available.

PMID:
21444875
11.

The stem cell niche in health and malignancy.

Burness ML, Sipkins DA.

Semin Cancer Biol. 2010 Apr;20(2):107-15. doi: 10.1016/j.semcancer.2010.05.006. Epub 2010 May 25. Review.

PMID:
20510363
12.

Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker?

Burness ML, Grushko TA, Olopade OI.

Cancer J. 2010 Jan-Feb;16(1):23-32. doi: 10.1097/PPO.0b013e3181d24fc1. Review.

PMID:
20164687
13.

Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells.

Feldman ED, Weinreich DM, Carroll NM, Burness ML, Feldman AL, Turner E, Xu H, Alexander HR Jr.

Ann Surg Oncol. 2006 Jan;13(1):125-33. Epub 2006 Jan 1.

PMID:
16378159

Supplemental Content

Loading ...
Support Center